Sexual identity differences in biomarkers of tobacco exposure among women in a national sample.
Sexual identity differences in biomarkers of tobacco exposure among women in a national sample.
复制标题
DOI:
10.1016/j.canep.2021.101980
复制
发表时间:
2021-10
影响因子:
2.6
通讯作者:
McCabe SE
中科院分区:
文献类型:
--
作者:
Evans-Polce RJ;Smith DM;Veliz P;Boyd CJ;McCabe SE
Sexual minority women are consistently at increased risk for tobacco use compared to heterosexual women. Neither biomarkers of nicotine exposure nor biomarkers of tobacco toxicant exposure have been examined by sexual identity. This study used interview and biomarker data from women in the biomarker core sample of Wave 1 of the Population Assessment of Tobacco and Health (PATH) study (2013–2014; n=4,930). We examined associations of sexual identity with nicotine exposure (measured with urinary cotinine and TNE-2) and with tobacco-specific nitrosamines (measured with urinary NNAL). Multivariable regression modeling was used to examine these associations among the full biomarker core sample, among past 30-day tobacco users, and among exclusive established cigarette users before and after controlling for tobacco use quantity and intensity. In the full biomarker sample of women, prior to adjusting for tobacco use quantity and intensity, bisexual women had significantly higher cotinine, TNE-2, and NNAL levels compared to heterosexual women. Among exclusive established cigarette users, gay/lesbian women had significantly higher NNAL compared to heterosexual women prior to adjusting for tobacco quantity and intensity. No differences by sexual identity were found after adjusting for tobacco use quantity and intensity. This is the first study to demonstrate differences in biological markers of tobacco exposure by sexual identity among women in the U.S. This has important public health implications as greater exposure to both nicotine and to tobacco-specific nitrosamines are strongly linked to cancer risk.
登录
查看更多内容
DOI:
10.1056/nejmsa1607538
发表时间:
2017-01-26
期刊:
The New England journal of medicine
影响因子:
--
作者:
Kasza KA;Ambrose BK;Conway KP;Borek N;Taylor K;Goniewicz ML;Cummings KM;Sharma E;Pearson JL;Green VR;Kaufman AR;Bansal-Travers M;Travers MJ;Kwan J;Tworek C;Cheng YC;Yang L;Pharris-Ciurej N;van Bemmel DM;Backinger CL;Compton WM;Hyland AJ
通讯作者:
Hyland AJ
DOI:
10.1158/1055-9965.epi-16-0675
发表时间:
2017-03
期刊:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子:
--
作者:
Chang CM;Edwards SH;Arab A;Del Valle-Pinero AY;Yang L;Hatsukami DK
通讯作者:
Hatsukami DK
DOI:
10.1158/1055-9965.epi-09-0874
发表时间:
2009-12
期刊:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子:
--
作者:
Goniewicz ML;Havel CM;Peng MW;Jacob P 3rd;Dempsey D;Yu L;Zielinska-Danch W;Koszowski B;Czogala J;Sobczak A;Benowitz NL
通讯作者:
Benowitz NL
DOI:
10.1176/appi.ajp.2020.20010005
发表时间:
2020-11-01
期刊:
The American journal of psychiatry
影响因子:
--
作者:
Evans-Polce RJ;Kcomt L;Veliz PT;Boyd CJ;McCabe SE
通讯作者:
McCabe SE
影响因子:
5.2
作者:
Hyland, Andrew;Ambrose, Bridget K.;Compton, Wilson M.
通讯作者:
Compton, Wilson M.